Faculty profile

Eleftherios Diamandis

ResearcherPathology and Laboratory MedicineUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Eleftherios Diamandis

Researcher

Pathology and Laboratory Medicine

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
3 publications in the last five years, latest in 2024.
Principal investigator on 20 research grants (11 NSERC, 9 CIHR), most recently in 2022.
Supervised 4 trainees who won CIHR awards, most recently in 2015.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Proteomics Drug Development Netherton Syndrome Crytallography Dmpk Studies In Vivo Efficacy Studies Ind Enabling Studies Kallikrein Inhibitors

Latest papers

Association of Free-to-Total PSA Ratio and 18F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide.
Acta haematologica · 2024
The roles of proteases in prostate cancer.
IUBMB life · 2023

All 12 publications

Latest funding

KaliDerm Therapeutics: A research/commercialization plan to validate, better define and add value to our proprietary dual KLK5/7 inhibitor as a novel topical therapeutic for Netherton Syndrome.
CIHR · 2022 · Nominated PI
$336,600
Real-time COVID-19 detection in wastewater from long-term care homes_x000d_ _x000d_ _x000d_
NSERC · 2020 · Co-investigator
$50,000
Integrative PersonalizedRiskand Therapy Stratification of Localized Prostate Cancer
CIHR · 2018 · Nominated PI
$450,000

All 33 grants and awards

12 publications.

Association of Free-to-Total PSA Ratio and 18F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study.

Bernardino RM, Lajkosz K, Yin LB, Sayyid RK, Wettstein M, Randhawa H, Cockburn JG, Ahmed S, Thomassian R, Diamandis E, Metser U, Berlin A, Fleshner NE

Journal of nuclear medicine : official publication, Society of Nuclear Medicine2024

DOI: 10.2967/jnumed.124.267877 PMID: 39327019

Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide.

Vasudevan Nampoothiri R, Avery L, Pasic I, Prassas I, Diamandis E, Michelis FV

Acta haematologica2024

DOI: 10.1159/000535706 PMID: 38330921

The roles of proteases in prostate cancer.

Koistinen H, Kovanen RM, Hollenberg MD, Dufour A, Radisky ES, Stenman UH, Batra J, Clements J, Hooper JD, Diamandis E, Schilling O, Rannikko A, Mirtti T

IUBMB life2023

DOI: 10.1002/iub.2700 PMID: 36598826

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia.

Kiebish MA, Tekumalla P, Ravipaty S, Dobi A, Srivastava S, Wu W, Patil S, Friss T, Klotz A, Srinivasan A, Cullen J, Rosner IL, Ali A, Laszlo S, Petrovic M, Fleshner N, Garren J, Miller G, Mahaveer Chand N, Rodrigues LO, Granger E, Kellogg MD, Luan S, Diamandis E, Akmaev VR, Sarangarajan R, Bountra C, Freedland SJ, McLeod DG, Narain NR

Scientific reports2021

DOI: 10.1038/s41598-021-94438-4 PMID: 34302010

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients

Fraser DD, Cepinskas G, Patterson EK, Slessarev M, Martin C, Daley M, Patel MA, Miller MR, O’Gorman DB, Gill SE

Critical Care Explorations202060 citationsSenior author

DOI: 10.1097/cce.0000000000000189

Simpson's paradox in proof-of-concept studies.

Janket SJ, Ackerson LK, Diamandis E

Nature medicine2019Senior author

DOI: 10.1038/s41591-019-0624-y PMID: 31636455

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.

Goldhardt O, Warnhoff I, Yakushev I, Begcevic I, Förstl H, Magdolen V, Soosaipillai A, Diamandis E, Alexopoulos P, Grimmer T

Translational neurodegeneration2019

DOI: 10.1186/s40035-019-0168-6 PMID: 31467673

Urinary adenosine excretion in type 1 diabetes.

Rajasekeran H, Lytvyn Y, Bozovic A, Lovshin JA, Diamandis E, Cattran D, Husain M, Perkins BA, Advani A, Reich HN, Kulasingam V, Cherney DZI

American journal of physiology. Renal physiology2017

DOI: 10.1152/ajprenal.00043.2017 PMID: 28381459

A Spectrum of Views on Clinical Mass Spectrometry.

Annesley T, Diamandis E, Bachmann L, Hanash S, Hart B, Javahery R, Singh R, Smith R

Clinical chemistry2016

DOI: 10.1373/clinchem.2015.250258 PMID: 26553793

Application of Modular Therapy for Renoprotection in Experimental Chronic Kidney Disease.

Kepecs DM, Zhang Y, Thai K, Advani SL, Yuen DA, Connelly KA, Kosanam H, Diamandis E, Sefton MV, Gilbert RE

Tissue engineering. Part A2015

DOI: 10.1089/ten.tea.2014.0017 PMID: 25661544

Something wrong or missing on this profile? Suggest a correction

Eleftherios Diamandis

Research

Latest papers

Latest funding

Association of Free-to-Total PSA Ratio and 18F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study.

Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide.

The roles of proteases in prostate cancer.

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia.

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients

Simpson's paradox in proof-of-concept studies.

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.

Urinary adenosine excretion in type 1 diabetes.

A Spectrum of Views on Clinical Mass Spectrometry.

Application of Modular Therapy for Renoprotection in Experimental Chronic Kidney Disease.

KaliDerm Therapeutics: A research/commercialization plan to validate, better define and add value to our proprietary dual KLK5/7 inhibitor as a novel topical therapeutic for Netherton Syndrome.

Real-time COVID-19 detection in wastewater from long-term care homes_x000d_ _x000d_ _x000d_

Integrative PersonalizedRiskand Therapy Stratification of Localized Prostate Cancer

BRCA1-induced pro-inflammatory signaling associated with ovarian cancer predisposition

Validation of subtype-specific ovarian cancer biomarkers for pelvic mass discrimination

Prediction of successful sperm retrieval in patients with non-obstructive azoospermia using TEX101 protein measured in seminal plasma by ELISA

Identification of molecular markers for the assessment of aggressive behaviour of small renal masses

Netherton Syndrome: From mechanism to therapies.

Validation of two novel pancreatic cancer biomarkers: CUZD1 and LAMC2

Prediction of successful sperm retrieval in patients with non-obstructive azoospermia using a panel of protein biomarkers measured in seminal plasma

Frequent collaborators

Andrew Advani

Claudio Martin

Vathany Kulasingam

Neil Fleshner

Antoine Dufour

Alejandro Berlin

Marat Slessarev

Lisa Avery

Daniel Cattran

Gediminas Cepinskas

Guillaume Pare

Mansoor Husain